, Tracking Stock Market Picks
Enter Symbol:
Encysive Pharmaceuticals Inc (ENCY) [hlAlert]

down 23.82 %

Encysive Pharmaceuticals Inc (ENCY) rated Sell

Posted on: Monday,  Nov 5, 2007  9:25 AM ET by UBS

UBS rated Sell Encysive Pharmaceuticals Inc (ENCY) on 11/05/2007. Previously UBS rated Sell Encysive Pharmaceuticals Inc (ENCY) on 08/07/2007., when
the stock price was $1.79. Since then, Encysive Pharmaceuticals Inc has gained 31.28% as of 09/25/2008's recent price of $2.35.
If you would have followed the previous UBS's recommendation on ENCY, you would have lost 23.82% of your investment in 415 days.

UBS is the leading global wealth manager, a top tier investment banking and securities firm, and one of the largest global asset managers. In Switzerland, UBS is the market leader in retail and commercial banking. With headquarters in Zurich and Basel, Switzerland, UBS operates in over 50 countries and from all major international centers. UBS employs more than 80,000 people.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/5/2007 9:25 AM Sell
1.19 1.00
as of 5/23/2009
1 Week   
1 Month   
3 Months   
1 YTD down  -176.47 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/7/2007 9:25 AM Sell
1.79 1.50

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy